Regulation (EU) 2024/2633
Commission Regulation (EU) 2024/2633 of 8 October 2024 amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for azoxystrobin, famoxadone, flutriafol, mandipropamid and mefentrifluconazole in or on certain products
In forceTyperegulationDate8 Oct 2024Since1 Jan 2025Articles2Versions held48Cited by1 documents
Source: EU legislation in force, consolidated versions and treaties (Cellar, Publications Office). Official publication. Reuse: Reuse authorised (Commission Decision 2011/833/EU).